Close Menu

This article has been updated from a previous version to include a statement from ERS Genomics on the EPO's decision regarding the Broad Institute's European patents.

NEW YORK (GenomeWeb) – Rockefeller University and the Broad Institute said this week that they have settled a dispute over the inventorship and ownership of certain CRISPR-Cas9 intellectual property, leaving the specifics of the IP unchanged.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Hastings Center's Erik Parens argues in a Scientific American opinion piece that the current pandemic underscores the need to reconsider the hope placed in genomic medicine. 

The Los Angeles Times writes that Operation Warp Speed has an ambitious timeline for developing a COVID-19 vaccine.

The Sydney Morning Herald reports that Australia is launching its trial of preconception carrier testing Tuesday.

In PNAS this week: autosomal genes commonly affected by loss-of-function variants, variants implicated in testis development disorders, and more.